Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Sylvie Rusakiewicz

A long non-coding RNA links calreticulin-mediated immunogenic cell removal to RB1 transcription

scientific article

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

scientific article published on 8 May 2011

Analysis of NKp30/NCR3 isoforms in untreated HIV-1-infected patients from the ANRS SEROCO cohort

scientific article published on March 2013

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

scientific article published on 5 November 2015

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article

Artificial exosomes as tools for basic and clinical immunology

scientific article published in April 2009

BCR/ABL-specific CD8+ T cells can be detected from CML patients, but are only expanded from healthy donors

scientific article published on 10 April 2009

Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma.

scientific article

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

scientific article published on 29 October 2015

Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients

scientific article

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.

scientific article published on 12 August 2015

Desirable cell death during anticancer chemotherapy

scientific article published on October 2010

Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response

scientific article

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

scientific article

Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article published in March 2015

Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma

scientific article published on 7 March 2017

Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors

scientific article

Immunogenicity of a recombinant lentiviral vector carrying human telomerase tumor antigen in HLA-B*0702 transgenic mice

scientific article published on 21 July 2010

Immunological off-target effects of imatinib

scientific article

Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis

scientific article published on 29 January 2016

Immunotherapeutic peptide vaccination with leukemia-associated antigens

scientific article published on 25 July 2006

Immunotherapy with alloreactive T-cells?

scientific article published on January 2004

Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma

scientific article published on 13 November 2013

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

scientific article published on 04 November 2021

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome

scientific article

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

scientific article published on 25 April 2016

NKp30 isoforms and NKp46 transcripts in metastatic melanoma patients: Unique NKp30 pattern in rare melanoma patients with favorable evolution

scientific article published on 10 March 2016

Natural killer cell mediated immunosurveillance of pediatric neuroblastoma

scientific article published on 5 May 2015

Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma

scientific article

Natural killer cells in non-hematopoietic malignancies

scientific article

Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy

scientific article

Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR(+) NK cell levels correlate with disease outcome

scientific article published on February 2013

Potent immunomodulatory effects of the trifunctional antibody catumaxomab

scientific article published on 4 June 2013

Predictors of responses to immune checkpoint blockade in advanced melanoma

scientific article published on 19 September 2017

Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer

scientific article published on 13 May 2016

Rationale for anti-OX40 cancer immunotherapy

scientific article

Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggering

scientific article published on 6 November 2013

Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on BRAFV600E Melanoma Lines with Vemurafenib

scientific article

Soluble HLA/peptide monomers cross-linked with co-stimulatory antibodies onto a streptavidin core molecule efficiently stimulate antigen-specific T cell responses

scientific article published on 5 May 2009

The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation

scientific article published on 23 May 2009

Witch hunt against tumor cells enhanced by dendritic cells

scientific article published on September 2009

Paulina is supported by:

About Paulina

Help